Suboptimal enrollment and retention efforts can compromise the quality of clinical trials. Barriers to enrolling marginalized populations include low awareness/education about clinical trials. Methods ...

Research programs in major depressive disorder (MDD) are in some cases shaped by perceived problems arising from the heterogeneity and non-additivity of placebo effects. A recent proposal in this ...

Two-year disease-free survival from evaluable Phase 2 patients expected by the end of Q1 2028. Strasbourg, France, April 13, 2026, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company ...